Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $16,705 | 821 | 81.6% |
| Consulting Fee | $2,823 | 3 | 13.8% |
| Travel and Lodging | $845.71 | 2 | 4.1% |
| Education | $95.57 | 5 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Optinose US, Inc. | $4,500 | 95 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $2,676 | 105 | $0 (2024) |
| CSL Behring | $1,836 | 84 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,733 | 103 | $0 (2024) |
| PFIZER INC. | $1,540 | 65 | $0 (2024) |
| GENZYME CORPORATION | $942.40 | 39 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $865.95 | 50 | $0 (2024) |
| Grifols USA, LLC | $810.73 | 34 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $670.86 | 31 | $0 (2024) |
| Genentech USA, Inc. | $644.54 | 27 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,613 | 107 | GENZYME CORPORATION ($401.64) |
| 2023 | $2,340 | 101 | AstraZeneca Pharmaceuticals LP ($613.70) |
| 2022 | $2,450 | 143 | PFIZER INC. ($317.49) |
| 2021 | $2,179 | 120 | AstraZeneca Pharmaceuticals LP ($373.90) |
| 2020 | $2,431 | 101 | OptiNose US, Inc. ($956.54) |
| 2019 | $2,416 | 105 | AstraZeneca Pharmaceuticals LP ($560.78) |
| 2018 | $4,967 | 98 | Optinose US, Inc. ($3,039) |
| 2017 | $1,072 | 56 | Boehringer Ingelheim Pharmaceuticals, Inc. ($277.38) |
All Payment Transactions
831 individual payment records from CMS Open Payments — Page 1 of 34
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $5.78 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/10/2024 | BioCryst US Sales Co., LLC | ORLADEYO (Drug) | Food and Beverage | In-kind items and services | $29.63 | General |
| Category: Immunology | ||||||
| 12/05/2024 | Grifols USA, LLC | Xembify (Biological) | Food and Beverage | In-kind items and services | $24.52 | General |
| Category: Immunology and Neurology | ||||||
| 12/03/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $28.55 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/21/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $20.92 | General |
| Category: Respiratory | ||||||
| 11/21/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $4.82 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/14/2024 | PFIZER INC. | OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug), PANZYGA, CUTAQUIG | Food and Beverage | In-kind items and services | $33.29 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2024 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $24.06 | General |
| 11/07/2024 | CSL Behring | Haegarda (Biological) | Food and Beverage | In-kind items and services | $35.77 | General |
| Category: Immunology | ||||||
| 11/05/2024 | ADMA BioManufacturing LLC | — | Consulting Fee | Cash or cash equivalent | $23.22 | General |
| 11/01/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $17.92 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 10/31/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $28.09 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 10/31/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: Respiratory | ||||||
| 10/29/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $29.53 | General |
| Category: Immunology | ||||||
| 10/29/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: DERMATOLOGY | ||||||
| 10/24/2024 | Novartis Pharmaceuticals Corporation | XOLAIR (Drug) | Food and Beverage | In-kind items and services | $32.37 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 10/23/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.41 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/17/2024 | BioCryst US Sales Co., LLC | ORLADEYO (Drug) | Food and Beverage | In-kind items and services | $25.99 | General |
| Category: Immunology | ||||||
| 10/16/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $22.19 | General |
| Category: Respiratory | ||||||
| 10/10/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $31.53 | General |
| Category: Immunology | ||||||
| 10/01/2024 | CSL Behring | Haegarda (Biological) | Food and Beverage | In-kind items and services | $22.72 | General |
| Category: Immunology | ||||||
| 09/26/2024 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $24.62 | General |
| 09/17/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $25.67 | General |
| Category: Immunology | ||||||
| 09/11/2024 | Grifols USA, LLC | Xembify (Biological) | Food and Beverage | In-kind items and services | $24.20 | General |
| Category: Immunology and Neurology | ||||||
| 09/05/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,106 | 16,964 | $838,975 | $329,376 |
| 2022 | 13 | 876 | 14,544 | $619,683 | $270,298 |
| 2021 | 12 | 785 | 14,943 | $683,744 | $314,844 |
| 2020 | 15 | 935 | 13,420 | $517,379 | $225,470 |
All Medicare Procedures & Services
57 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J2357 | Injection, omalizumab, 5 mg | Office | 2023 | 33 | 8,101 | $552,510 | $243,206 | 44.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 137 | 198 | $43,824 | $17,749 | 40.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 114 | 114 | $36,615 | $14,173 | 38.7% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2023 | 56 | 1,145 | $33,635 | $13,163 | 39.1% |
| 95004 | Test for allergy using allergenic extract | Office | 2023 | 74 | 3,821 | $57,358 | $11,566 | 20.2% |
| 95117 | Professional service for multiple injections of allergen | Office | 2023 | 112 | 728 | $27,576 | $5,722 | 20.7% |
| 95024 | Test for allergy using allergenic extract injected into skin | Office | 2023 | 54 | 741 | $13,558 | $4,648 | 34.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 63 | 440 | $23,450 | $4,360 | 18.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 54 | 60 | $9,054 | $3,756 | 41.5% |
| 95044 | Test for allergy using skin patch | Office | 2023 | 11 | 835 | $13,015 | $3,036 | 23.3% |
| 95115 | Professional service for single injection of allergen | Office | 2023 | 49 | 242 | $7,160 | $1,670 | 23.3% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2023 | 12 | 12 | $2,325 | $1,570 | 67.5% |
| 95018 | Test for allergy using combination of methods with drug or biological | Office | 2023 | 16 | 95 | $4,287 | $1,499 | 35.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 17 | 17 | $3,542 | $1,144 | 32.3% |
| 94375 | Test to measure rate of airflow | Office | 2023 | 26 | 28 | $2,323 | $815.81 | 35.1% |
| 96160 | Administration and interpretation of patient-focused health risk assessment | Office | 2023 | 260 | 368 | $6,384 | $725.70 | 11.4% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 18 | 19 | $2,360 | $573.99 | 24.3% |
| J2357 | Injection, omalizumab, 5 mg | Office | 2022 | 28 | 6,690 | $408,090 | $194,661 | 47.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 111 | 182 | $34,580 | $16,455 | 47.6% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2022 | 63 | 1,430 | $38,610 | $16,376 | 42.4% |
| 95004 | Test for allergy using allergenic extract | Office | 2022 | 69 | 3,721 | $48,373 | $11,937 | 24.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 88 | 88 | $25,520 | $10,499 | 41.1% |
| 95024 | Test for allergy using allergenic extract injected into skin | Office | 2022 | 52 | 797 | $11,557 | $5,298 | 45.8% |
| 95117 | Professional service for multiple injections of allergen | Office | 2022 | 125 | 649 | $20,768 | $5,270 | 25.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 47 | 320 | $14,400 | $3,273 | 22.7% |
About Dr. Timothy Campbell, M.D
Dr. Timothy Campbell, M.D is a Allergy & Immunology healthcare provider based in Williamsburg, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/26/2009. The National Provider Identifier (NPI) number assigned to this provider is 1891923074.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Timothy Campbell, M.D has received a total of $20,469 in payments from pharmaceutical and medical device companies, with $2,613 received in 2024. These payments were reported across 831 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($16,705).
As a Medicare-enrolled provider, Campbell has provided services to 3,702 Medicare beneficiaries, totaling 59,871 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 57 distinct procedure/service records.
Practice Information
- Specialty Allergy & Immunology
- Location Williamsburg, VA
- Active Since 06/26/2009
- Last Updated 11/01/2023
- Taxonomy Code 207K00000X
- Entity Type Individual
- NPI Number 1891923074
Products in Payments
- Xhance (Drug) $4,500
- NUCALA (Biological) $1,491
- DUPIXENT (Biological) $1,483
- Haegarda (Biological) $1,058
- EUCRISA (Drug) $1,000
- FASENRA (Biological) $793.99
- FASENRA (Drug) $762.99
- Hizentra (Biological) $746.07
- TEZSPIRE (Biological) $686.04
- Xolair (Biological) $644.54
- AUVI-Q (Drug) $542.99
- CUVITRU (Biological) $536.23
- Xembify (Biological) $499.64
- TAKHZYRO (Biological) $463.93
- ORLADEYO (Drug) $404.37
- RUCONEST (Biological) $342.14
- Prolastin-C Liquid (Biological) $311.09
- OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug) $279.95
- SPIRIVA RESPIMAT (Drug) $251.88
- AYVAKIT (Drug) $231.22
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Allergy & Immunology Doctors in Williamsburg
Eric Karlin, M.d, M.D
Allergy & Immunology — Payments: $448,118
Dr. Stephen Shield, M.d, M.D
Allergy & Immunology — Payments: $91,933
Robert Brooks, Md, MD
Allergy & Immunology — Payments: $31.10
Joan Brauckmann, Md, MD
Allergy & Immunology